What Are Clinical Trials?

Clinical trials are carefully controlled research studies in which volunteers work with researchers to explore new ways to prevent, detect, or treat various conditions. Led by doctors and clinical researchers, these studies are designed to evaluate the safety and effectiveness of new treatments, including medications, medical devices, or vaccines.

These trials play a critical role in the process of bringing new treatments that have already shown promise in early testing. As the final phase of evaluation, they provide the necessary data for regulatory bodies before approval and public access.

Each clinical trial follows a detailed protocol that has been reviewed and approved by regulatory agencies and ethics committees, ensuring that the study is conducted safely and ethically while providing reliable results.

While many people think of clinical trials as simply testing new medications, they actually cover much more. Researchers study everything from groundbreaking surgical procedures and medical devices to innovative diagnostic tools and drugs. Some trials focus on finding new ways to use existing treatments more effectively and others examine how changes in lifestyle, like specific dietary programs or exercise routines, might improve health outcomes.

With this understanding of what clinical trials are, let’s delve into their purpose and importance in advancing healthcare. These studies not only improve patient care but also play a vital role in driving medical breakthroughs, shaping the future of treatment options, and ultimately enhancing the quality of life for patients worldwide.

The true value of clinical trials lies in their ability to transform innovative ideas into real-world medical solutions. These studies don’t just explore whether a treatment works—they provide the critical data and evidence needed to improve patient care, set new standards in healthcare, and drive medical innovation forward.

Through careful research, clinical trials aim to answer fundamental medical questions such as:

• Is a new treatment, diagnostic tool, or vaccine safe?
• How treatments compare to current standards of care
• What side effects might occur?
• How does it affect certain diseases or conditions?

This rigorous evaluation process ensures that by the time new treatments become available, both doctors and patients can have confidence in their safety and effectiveness, while also providing the critical data regulatory agencies need to determine whether a treatment should be approved for public use.

But the success of clinical trials depends on one crucial element: participation. For many patients, joining a clinical trial offers access to cutting-edge treatments not yet available to the public, which can be especially vital for those with conditions that haven’t responded to standard therapies.

Beyond personal benefits, participants play an essential role in advancing medical knowledge. Clinical trials enable researchers to translate groundbreaking discoveries into practical treatments, accelerating the development of therapies that address previously untreatable conditions. Without these studies—and the volunteers who make them possible—the path from research to patient care would be far slower.

The purpose of a clinical trial not only drives its goals but also determines its structure, guiding researchers to select the appropriate type of study. Whether to measure the efficacy of a new intervention before it proceeds further in development or to gather Real-World Evidence (RWE) about its use in practical settings. Clinical trials fall into two main categories: interventional and observational studies. Both play vital roles in advancing medical knowledge but serve different purposes based on their approach to answering medical questions. Let’s take a closer look at each.

Clinical trials fall into two main categories: interventional and observational studies. Both play vital roles in advancing medical knowledge but they serve different purposes based on their approach to answering medical questions.

Interventional studies directly evaluate the impact of a specific treatment, procedure, or preventative measure. Participants are divided into groups, with at least one group receiving an intervention (e.g., a new drug, medical device, or therapy). The effects of this intervention are compared to those in another group, which may receive a standard treatment, a different intervention, or a placebo (an inactive substance designed to mimic the treatment without any therapeutic effect, used to measure the true impact of the intervention).

These studies are often conducted in four phases, each one building on the results of the previous one. This phased approach ensures that safety and efficacy are thoroughly evaluated at every step, providing a structured way to understand the treatment’s potential impact.

Observational studies differ from interventional trials in that they don't involve specific treatments or interventions. Instead, researchers monitor participants to gather data about their health, lifestyle, and disease progression. These studies aim to uncover patterns, risk factors, or correlations that can guide future treatments or preventative strategies.

Patients continue their usual care routines, and researchers observe outcomes without altering treatment plans. Common goals of observational studies include understanding disease natural history, identifying risk factors, and optimizing current treatment approaches.

Studies for various conditions can be interventional (introducing new treatments, tests, or preventive measures) or observational (monitoring outcomes without intervention). Common types include:

• Treatment Trials: Assess the efficacy and safety of treatments or interventions. Typically interventional but can be observational in real-world settings.

• Prevention Trials: Test or observe strategies to prevent diseases or recurrences.

• Diagnostic Trials: Develop or improve diagnostic tests, either through active intervention or observational analysis.

• Quality of Life Trials: Focus on improving well-being, often interventional but can be observational in current care studies.

• Screening Trials: Evaluate methods for early disease detection, either by testing new approaches (interventional) or studying existing practices (observational).

Each trial type may adopt an interventional or observational approach based on its goals.

Before any potential treatment even reaches the stage of being tested in humans, it must first pass through a rigorous process to ensure it’s safe and has the potential to be effective. This journey begins long before clinical trials. Let’s explore one example: the pathway of a new drug through the drug development process.

Keep in mind that other medical innovations—such as vaccines, medical devices, biologics, and diagnostic tools—follow similarly stringent paths to ensure their safety and effectiveness before reaching clinical trials. The process starts with thousands of compounds, each representing a potential treatment. Through research and testing, only a small fraction of these candidates make it through the various stages.

Scientists begin by screening up to 20,000 compounds in the lab. They aim to identify which ones show promise in targeting a disease or condition. This phase involves early research, including chemistry, biology, and pharmacology studies.

The most promising 250 compounds are tested in laboratory and animal studies to gather preliminary data on safety, dosing, and biological activity. At this stage, researchers evaluate whether the compound could potentially work in humans.

Before moving forward to human trials, the trial sponsor (which could be a pharmaceutical company, academic institution, or other entity) submits an Investigational New Drug (IND) application to the relevant regulatory body, such as the FDA (the Food and Drug Administration of the USA).

This application includes:

• Results from pre-clinical studies.

• Details on how the drug is made.

• The proposed clinical trial design, including protocols to protect participants.

Once the IND is approved, the treatment enters clinical trials, which are conducted in three main phases (Phases 1, 2, and 3) to test the treatment in humans assessing its safety, effectiveness, and potential side effects. Out of the initial thousands of compounds, from one to five compounds typically make it to this stage.

As mentioned above, clinical trials generally fall into two categories: interventional and observational. Interventional trials actively test a specific treatment, such as a drug or medical device, by assigning participants to treatment groups, while observational trials monitor participants in real-world settings to gather insights on health outcomes without altering their standard care.

In some cases, trials may include an earlier stage called Phase 0, which focuses on understanding how a treatment behaves in the body using a very small number of participants or Phase 4 trials that are conducted after a drug has been approved and licensed, aiming to monitor its long-term safety and effectiveness in broader populations.

NDA Submission:

After successful clinical trials, the sponsor submits a New Drug Application (NDA) to the relevant regulatory body which includes all data from pre-clinical and clinical studies. The relevant regulatory body reviews the information to determine if the treatment should be approved for public use.

Approved Drug and Post-Approval:

Once approved, the treatment is manufactured and continues to be monitored to track its long-term safety and effectiveness in a larger, more diverse patient population.

Clinical trials are at the heart of medical progress, turning innovative ideas into treatments that improve lives. They’re essential for advancing our understanding of health and disease, bringing new therapies, devices, and preventative strategies to patients who need them.

Whether you’re curious about how new treatments are developed or looking for ways to learn more about healthcare advancements, understanding clinical trials helps you stay informed and empowered.

At Patlynk, we’re passionate about connecting people with reliable information and resources on clinical trials. Explore our platform to discover how clinical trials shape the future of medicine and improve care for patients everywhere.